New stock news | Ying'nuo Pharmaceutical's Hong Kong IPO prospectus failed

According to the Wise Finance app, the Hong Kong stock prospectus submitted by Guangzhou Yinnuo Pharmaceutical Group Co., Ltd. (Yinnuo Pharmaceutical) on December 3, 2024, expired on June 3, 2025, after 6 months. China CITIC Securities and CICC were its joint sponsors at the time of submission.